Viewing Study NCT04152057

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-01-24 @ 9:29 AM
Study NCT ID: NCT04152057
Status: UNKNOWN
Last Update Posted: 2019-11-05
First Post: 2019-10-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer
Sponsor: West China Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None HER2 Positive View
None Combination Chemotherapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pyrotinib Maleate Tablets View
None Trastuzumab View
None Albumin Paclitaxel View
None Early or Locally Advanced View
None neoadjuvant View